H. Lundbeck A/S (Lundbeck) and Ovation Pharmaceuticals, Inc. (Ovation) announced that they have entered into a definitive transaction agreement under which Lundbeck, through the wholly owned subsidiary Lundbeck, Inc., will acquire Ovation in an all cash transaction valuing Ovation at up to USD 900 million or approximately DKK 5.2 billion.
The details can be read here.
No comments:
Post a Comment